ACAD
31.7
0.00
0.00%
AEMD
0.25
-0.02
-6.81%
APRI
1.22
0.00
0.00%
ARNA
4.77
0.00
0.00%
ATEC
1.32
0.00
0.00%
CFN
59.74
0.00
0.00%
CNAT
6.09
0.00
0.00%
CRXM
0.2
0.00
-0.01%
CYTX
0.5
0.00
0.00%
DXCM
62.32
0.00
0.00%
GNMK
13.51
0.00
0.00%
HALO
14.48
0.00
0.00%
ILMN
203.25
0.00
0.00%
INNV
0.2
-0.03
-11.16%
INO
8.94
0.00
0.00%
ISCO
0.06
0.00
0.00%
ISIS
72.4
0.00
0.00%
LGND
58.56
0.00
0.00%
LPTN
2.94
0.00
0.00%
MBVX
1.11
-0.06
-5.13%
MEIP
3.69
0.00
0.00%
MNOV
3.46
0.00
0.00%
MRTX
20.98
0.00
0.00%
MSTX
0.46
0.00
0.00%
NBIX
33.54
0.00
0.00%
NUVA
46.93
0.00
0.00%
ONCS
0.39
0.00
-0.88%
ONVO
6.59
0.00
0.00%
OREX
5.67
0.00
0.00%
OTIC
34.42
0.00
0.00%
QDEL
24.96
0.00
0.00%
RCPT
116.69
0.00
0.00%
RGLS
18.9
0.00
0.00%
RMD
65.2
0.00
0.00%
SCIE
0.01
0.00
0.00%
SPHS
0.49
0.00
0.00%
SRNE
10.62
0.00
0.00%
TROV
5.95
0.00
0.00%
VICL
1.03
0.00
0.00%
VOLC
17.97
0.00
0.00%
ZGNX
1.39
0.00
0.00%
Home » Events, Uncategorized

SDBDG BioTalk

Submitted by on September 27, 2009 – 2:16 pm

The Novelix Challenge: Developing Next Generation
Dermatology Drugs in a Low-Cost Virtual Environment
Burkhard Jansen, MD, PhD – CEO

September 30, 2009 5:30 – 8:00 pm (Announcements begin at 6:30 pm)

AT SORRENTO SUMMIT

Meetings are open to everyone and free of charge
[[Click here for more information.]]

Leave a comment!

Add your comment below, or trackback from your own site. You can also Comments Feed via RSS.

Be nice. Keep it clean. Stay on topic. No spam.

You can use these tags:

<a href="" title="" rel=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong> 

This is a Gravatar-enabled weblog. To get your own globally-recognized-avatar, please register at Gravatar.


× 1 = three